智能纳米体系研究

1、科研项目
中国博士后管理委员会，中国博士后科学基金第70批面上资助，2021M703598，催化乳酸代谢诱导铁死亡的纳米反应器在转移性乳腺癌治疗中的应用，2022.01-2023.12，8万，在研，主持。

1.Xu, Y.; Huang, L.L.; Bi, Y.Y.; Song, Q.; Zhang, M.M.; Zhang, L.F.; Zhou, T.J.*, Xing, L.*; Jiang, H.L.* Dual inhibition of glucose uptake and energy supply synergistically restrains the growth and metastasis of breast cancer. Chinese Chem Lett. 2022; In press. (IF: 8.455)
2.Zhou, T.J.#; Xu, Y.#; Gong, Y.H.#; Yu, M.T.; Xu, E.Z.; Aimaiti, W.; Ma, R.J.; Xing, L.; Wen, H.*; Wang, J.H.*; Jiang, H.L.* Breaking-then-curing strategy for efficient cystic echinococcosis therapy. Chinese Chem Lett. 2022;33:2949-2953. (IF:6.779)
3.Zhou, T.J.; Xu, Y.; Xing, L.; Wang, Y.; Jiang, H.L.* A harmless-harmful switchable and uninterrupted laccase-instructed killer for activatable chemodynamic therapy. Adv Mater 2021;33:e00114. (IF: 30.849)
4.Xing, L.#; Liu, X.Y.#; Zhou, T.J.#; Wan, X.; Wang, Y.; Jiang, H.L.* Photothermal nanozyme-ignited Fenton reaction-independent ferroptosis for breast cancer therapy. J Control Release. 2021;339:14-26. (IF: 9.776)
5.Wang, Y.#; Hu, L.F.#; Zhou, T.J.#; Qi, L.Y.; Xing, L.; Lee, J.; Wang, F.Z.*; Oh, Y.K.*; Jiang, H.L.* Gene therapy strategies for rare monogenic disorders with nuclear or mitochondrial gene mutations. Biomaterials. 2021;277:121108. (IF: 12.479)
6.Zhou, T.J.#; Xing, L.#; Fan, Y.T.; Cui, P.F.; Jiang, H.L.* Light triggered oxygen-affording engines for repeated hypoxia-resistant photodynamic therapy. J Control Release. 2019;307:44-54. (IF: 7.727)
7.Zhou, T.J.#; Xing, L.#; Fan, Y.T.#; Cui, P.F.; Jiang, H.L.* Inhibition of breast cancer proliferation and metastasis by strengthening host immunity with a prolonged oxygen-generating phototherapy hydrogel. J Control Release. 2019;309:82-93. (IF: 7.727)
8.Shen, L.J.#; Zhou, T.J.#; Fan, Y.T.; Chang, X.; Wang, Y.; Sun, J.; Xing, L.*; Jiang, H.L.* Recent progress in tumor photodynamic immunotherapy, Chinese Chem Lett 2020;31:1709-1716. (IF: 6.779)
9.Fan, Y.T.#; Zhou, T.J.#; Cui, P.F.; He, Y.J.; Chang, X.; Xing, L.*; Jiang H.L.* Modulation of intracellular oxygen pressure by dual‐drug nanoparticles to enhance photodynamic therapy. Adv Funct Mater 2019;29:1806708. (IF: 16.836)
10.Luo, C.Q.#, Zhou, Y.X.#, Zhou, T.J.#, Xing, L., Cui, P.F., Sun, M., Jin, L., Lu, N.*, Jiang, H.L.*. Reactive oxygen species-responsive nanoprodrug with quinone methides-mediated GSH depletion for improved chlorambucil breast cancers therapy. J Control Release. 2018;274:56-68. (IF: 7.901)